Publication | Closed Access

Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity

NanomedicineDrug TargetingGsh-responsive Paclitaxel-ss-berberine ConjugatePolymer-drug ConjugateMedicineTherapeutic NanomaterialsSynergetic Cancer TreatmentEnhanced CytotoxicityTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer Research